Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

Clinical trial NCT01716533 · COMPLETED

Trial details

NCT number: NCT01716533
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Infections, Clostridium Difficile

Start date: 2013-02-02
Primary completion: 2015-06-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.